The “intention to treat analysis” showed a risk reduction (18.9%) in the combined endpoints, major plus minor events, in the picotamide group compared with the controls, which, however, did not reach statistical significance; conversely, “on treatment analysis” showed a higher and statistically significant reduction (22.8%) in the same endpoints.
← all excerpts
A review of picotamide in the reduction of cardiovascular events in diabetic patients.
1
—
—